Smith & Nephew hit by currency headwinds
28th Jul 2016 08:35
(ShareCast News) - Interim profits at medical technology firm Smith & Nephew were hit by currency headwinds, the company said on Thursday. Pre-tax profits for the period fell to $453m from $481m while trading profits were lower at $483m compared with $512m a year ago. Group revenue for the first ha
Read moreBurberry replaces Bailey as CEO with Céline's Gobbetti
11th Jul 2016 13:56
(ShareCast News) - Burberry chief executive Christopher Bailey has been replaced in the role after less than three years by Marco Gobbetti, currently boss of LVMH's Céline luxury brand, as the Yorkshireman steps back to focus solely on the role of chief creative officer. The FTSE 100 fashion house a
Read moreSmith & Nephew cuts cord on gynaecology unit to fund USD300m buyback
18th May 2016 13:25
(ShareCast News) - Smith & Nephew has agreed to sell its gynaecology business for $350m to New York-based Medtronic, of which $300m will be returned to shareholder via a share buyback. The London- and New York-listed medical technology business said the proceeds were surplus to its current capital r
Read moreMonday broker round-up
9th May 2016 15:26
(ShareCast News) - Easyjet: RBC upgrades to outperform with a 1500p target. Restaurant Group: UBS downgrades to neutral with a 305p target. Burberry: Barclays keeps at equal-weight with a 305p target. Smith & Nephew: Berenberg reiterates buy with a target of 1300p and Barclays stays at overweight
Read moreFTSE 100 movers: Forecasts lift TUI while iron send miners plunging
9th May 2016 14:31
(ShareCast News) - The FTSE 100 was just above the waterline in afternoon trading on Monday, having retraced earlier gains as oil prices slipped back. Two major players in the travel sector featured highly in the risers, with TUI surging ahead of its half-year results on Wednesday. The tour operato
Read moreJefferies upgrades Smith & Nephew to 'buy'
9th May 2016 10:08
(ShareCast News) - Jefferies upgraded artificial knee and hip maker Smith & Nephew to 'buy' from 'hold' and lifted the price target to 1,375p from 1,044p. The bank pointed out that S&N has rebalanced away from hips and knees and now has leading positions in higher-growth segments. Jefferies said it
Read moreSmith & Nephew Q1 sales hit by China weakness
5th May 2016 07:32
(ShareCast News) - Artificial knee and hip maker Smith & Nephew posted a 3% rise in first-quarter revenue, as a solid performance in the US was offset by weakness in China. For the quarter ended 2 April, revenue nudged up to $1.14bn from $1.10bn in the same period last year, which was below the $1.1
Read moreMonday broker round-up
25th Apr 2016 13:13
(ShareCast News) - Ted Baker: Jefferies upgrades to buy with a 3000p target. Howden Joinery Group: Goldman Sachs upgrades to neutral with a 515p target. Genel Energy: Barclays keeps at overweight with a target price of 115p and Canaccordreiterates speculative buy with a target of 165p. Royal Dutch
Read moreTuesday broker round-up
12th Apr 2016 19:38
(ShareCast News) - Vesuvius: Jefferies downgrades to sell with a target price of 255p. Ashtead: HSBC downgrades to hold with a target price of 970p. Cairn Energy: Canaccord reiterates hold with a target price of 215p. Just Eat: JP Morgan keeps at outperform with a target of 775p. Vedanta: Jefferi
Read moreThursday broker round-up
11th Feb 2016 13:52
(ShareCast News) - ARM Holdings: JP Morgan reiterates neutral with a target of 950p, Exane BNP Paribas keeps at outperform, 1300p target, Deutsche Bank stays at hold, 1000p target, Goldman Sachs maintains buy with a target of 1400p, Citigroup keeps at neutral and Bryan, Garnier & Co reiterates buy.
Read moreBroker tips: Smith & Nephew, Pennon, Halma
11th Feb 2016 11:55
(ShareCast News) - Smith & Nephew shares plunged on Thursday after UBS downgraded the company to 'neutral' on concerns about margin expansion. The investment bank said in a note that it has previously rated the company at 'buy' on the opportunity for margin expansion driven by a recovery in the Woun
Read moreUBS cuts Smith & Nephew rating on margin expansion concerns
11th Feb 2016 10:13
(ShareCast News) - Smith & Nephew shares plunged on Thursday after UBS downgraded the company to 'neutral' on concerns about margin expansion. The investment bank said in a note that it has previously rated the company at 'buy' on the opportunity for margin expansion driven by a recovery in the Woun
Read moreThursday broker round-up
4th Feb 2016 16:07
(ShareCast News) - Coca-Cola HBC: Barclays downgrades to underweight with a target of 1325p. TalkTalk: Goldman Sachs downgrades to neutral with a target of 271p. Paragon Group: JP Morgan downgrades to neutral and sets a 380p target. Antofagasta: Investec reiterates sell with a target of 305p. Ang
Read moreSmith and Nephew revenue flat while full year profit dips
4th Feb 2016 08:05
(ShareCast News) - Smith & Nephew's full year revenue has remained flat for the year to 31 December 2015, while reported operating profit dipped. The FTSE 100 medical device company said full year revenue was $4.634bn (£3.172bn), flat compared to 2014's revenue of $4.617bn. Underlying growth was 5%
Read moreSmith & Nephew CEO diagnosed with cancer
1st Feb 2016 07:35
(ShareCast News) - Smith & Nephew's chief executive officer Olivier Bohuon has been diagnosed with cancer, it was revealed on Monday. The FTSE 100 medical technology firm described the form of cancer as "highly treatable", and said Bohuon would remain chief executive officer and be actively involved
Read more